期刊文献+

益肾通络方对自发性膜性肾病患者内皮细胞功能的影响 被引量:4

The effect of Yishentongluo recipe on endothelial cell function of idiopathic membranous nephropathy patients
下载PDF
导出
摘要 目的观察益肾通络方对自发性膜性肾病(IMN)患者24h尿蛋白(24hTP)定量、血浆白蛋白(Alb)、组织纤溶酶原激活因子(t-PA)、Ⅰ型纤溶酶原激活因子抑制因子(PAI-1)及内皮素-1(ET-1)的影响,探讨其部分作用机制。方法72例经肾脏穿刺病理诊断为IMN(病理分期Ⅰ及Ⅱ期)、肾功能正常的患者,随机分为治疗组和对照组。对照组给予基础治疗,治疗组加服益肾通络中药。另设健康志愿者30例为健康组。结果治疗前,治疗组及对照组与健康组比较,PAI-1及ET-1均显著增高(均P<0.01),t-PA显著降低(P<0.01);治疗后与对照组比较,治疗组24hTP明显降低(P<0.01),Alb和t-PA显著升高(P<0.01,P<0.05),PAI-1和ET-1显著下降(P<0.05,P<0.01)。结论益肾通络方能够降低IMN(Ⅰ、Ⅱ期)患者24hTP、PAI-1及ET-1,升高Alb、t-PA水平。 Objective By observing the effect of Yishentongluo recipe on 24 h urine protein(24 h TP),plasma-albumin(Alb),tissue plasminogen activator(t-PA),type-1 plasminogen activator inhibitor(PAI-1) and endothelin-1 to explore the action mechanism.Methods 72 disagnosed as idiopathic membranous nephropathy(IMN Ⅰ,Ⅱ phase) by kidney paracentesis pathological diagnosis with normal kidney function were randomly divided into treatment and control groups.The control group was given basic treatment,treatment group was added Yishentongluo recipe.The other 30 healthy control was as healthy group.Results Before treatment,compared with healthy group,the other two groups had the enhanced PAI-1,ET-1(all P〈0.01),the decreased t-PA(P〈0.01).After treatment,compared with control group,the treatment group had the decreased 24 h TP,PAI-1 and ET-1(P〈0.01,P〈0.05,P〈0.01),the enhanced Alb,t-PA(P〈0.01,P〈0.05).Conclusions Yishentongluo recipe could descend 24 h TP,PAI-1 and ET-1,and enhance Alb,t-PA level of IMN patients.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2009年第20期2564-2565,共2页 Chinese Journal of Gerontology
基金 河北省科技厅科技攻关课题(No.08206115D)
关键词 益肾通络方 自发性膜性肾病(IMN) 内皮细胞功能 Yishentongluo recipe Idiopathic membranous nephropathy Endothelial cell function
  • 相关文献

参考文献6

二级参考文献16

  • 1薛永亮,田爱兰,王建军.益气活血化瘀中药对血管内皮功能的保护作用的实验研究[J].河南中医学院学报,2006,21(2):29-30. 被引量:17
  • 2王振生.临床纤维蛋白溶解的研究进展[J].国外医学:输血及血液学分册,1988,11:252-255. 被引量:2
  • 3Tsuyoshi O, Michael F, Wilbur L, et al. Modulation od plasmanogen activator inhibitor-1 in vivo:A new mechanism for the anti-fibrotic effect of rennin-agiotensin inhibitor.Kidney Int, 1997,51:164-172. 被引量:1
  • 4Yoshida Y, Shiiki H, Iwano M, et al. Enhanced expression of plasminogen activator inhibitor 1 in patients with nephrotic syndrome. Nephron,2001,88(1):24-29. 被引量:1
  • 5Hamano K, Iwano M, Akai Y, et al. Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Am J Kidney Dis,2002,39(4):695-705. 被引量:1
  • 6Banach-Wawrzenczyk E, Dziedziczko A, et al.Fibrinolytic system in bronchial asthma after prednisone treatment. Pol Merkuriusz Lek,2000,7(43):9-11. 被引量:1
  • 7余霞君,中华肾脏病杂志,1992年,8卷,140页 被引量:1
  • 8团体著者,中华儿科杂志,1979年,4卷,248页 被引量:1
  • 9戴玉璋.实用中医肾病学[M].北京:人民卫生出版社,2002.637 被引量:2
  • 10Willam HB ,Shirley LC ,Samir SE ,et al. ECM degradation by cultured human mesangial cell is mediated by a PA/plamin/MMP-2casacade[ J]. Kidey Int , 1995,47 : 1039-1047. 被引量:1

共引文献41

同被引文献85

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部